van Hootegem Sander J M, van der Linde Margrietha, Schneider Marcel A, Kim Jeesun, Berlth Felix, Sugita Yutaka, Grimminger Peter P, Baiocchi Gian Luca, De Manzoni Giovanni, Bencivenga Maria, Gisbertz Suzanne, Nunobe Souya, Yang Han-Kwang, Gutschow Christian A, Lagarde Sjoerd M, Lingsma Hester F, Wijnhoven Bas P L
Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.
Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands.
Br J Surg. 2025 Mar 28;112(4). doi: 10.1093/bjs/znaf043.
To reduce the clinical and economic burden of complications after gastrectomy for gastric cancer, specific complications should be targeted to effectively allocate healthcare resources for quality improvement and preventive measures. The aim of this study was to assess the impact of complications on clinical outcomes.
This was a retrospective multicentre study of patients who underwent (sub)total gastrectomy for gastric or junctional adenocarcinoma at 43 centres in 16 countries between 2017 and 2021. Outcomes were escalation of care, reoperation, prolonged hospital stay (greater than the 75th percentile), readmission, and 30-day mortality. Adjusted relative risks and population attributable fractions were estimated for specific complication-outcome pairs. The population attributable fraction represents the percentage reduction in the frequency of an adverse outcome if a complication could be completely prevented in the population.
In total, 7829 patients were included. Postoperative complications occurred in 1884 patients (24.1%). The most frequent complications were pulmonary complications (436 patients (5.6%)), anastomotic leakage (363 patients (4.6%)), and abdominal collection (301 patients (3.8%)). Anastomotic leakage, cardiac complications, and pulmonary complications had the greatest impact on 30-day mortality (population attributable fraction 26.6% (95% c.i. 14.5% to 38.6%), 18.7% (95% c.i. 9.4% to 28.0%), and 15.6% (95% c.i. 12.0% to 30.0%) respectively). Anastomotic leakage and pulmonary complications had the greatest impact on escalation of care (population attributable fraction 26.3% (95% c.i. 20.6% to 32.0%) and 18.4% (95% c.i. 11.7% to 25.2%) respectively), whereas anastomotic leakage and intra-abdominal bleeding had the greatest impact on reoperation (population attributable fraction 31.6% (95% c.i. 26.4% to 36.9%) and 8.5% (95% c.i. 5.5% to 11.5%) respectively). Most of the studied complications contributed to a prolonged hospital stay, whereas the contribution of complications to readmission did not exceed 15.9%. Subgroup analysis showed regional variation in the impact of complications.
Anastomotic leakage had the largest overall negative impact on clinical outcomes after gastrectomy for gastric adenocarcinoma. Reducing the incidence of anastomotic leakage and pulmonary complications would have the most impact on the burden of complications.
为减轻胃癌胃切除术后并发症的临床和经济负担,应针对特定并发症有效分配医疗资源,以改善医疗质量并采取预防措施。本研究旨在评估并发症对临床结局的影响。
这是一项回顾性多中心研究,研究对象为2017年至2021年间在16个国家的43个中心接受胃或交界腺癌(次)全胃切除术的患者。结局指标包括医疗升级、再次手术、住院时间延长(超过第75百分位数)、再次入院和30天死亡率。对特定并发症 - 结局对估计调整后的相对风险和人群归因分数。人群归因分数表示如果在人群中能够完全预防一种并发症,不良结局发生频率降低的百分比。
共纳入7829例患者。1884例患者(24.1%)发生术后并发症。最常见的并发症是肺部并发症(436例患者(5.6%))、吻合口漏(363例患者(4.6%))和腹腔积液(301例患者(3.8%))。吻合口漏、心脏并发症和肺部并发症对30天死亡率的影响最大(人群归因分数分别为26.6%(95%置信区间14.5%至38.6%)、18.7%(95%置信区间9.4%至%)和15.6%(95%置信区间12.0%至30.0%))。吻合口漏和肺部并发症对医疗升级的影响最大(人群归因分数分别为26.3%(95%置信区间20.6%至32.0%)和18.4%(95%置信区间11.7%至25.2%)),而吻合口漏和腹腔内出血对再次手术的影响最大(人群归因分数分别为31.6%(95%置信区间26.4%至36.9%)和8.5%(95%置信区间5.5%至11.5%))。大多数研究的并发症导致住院时间延长,而并发症对再次入院的影响不超过15.9%。亚组分析显示并发症影响存在地区差异。
吻合口漏对胃腺癌胃切除术后的临床结局总体负面影响最大。降低吻合口漏和肺部并发症的发生率对并发症负担的影响最大。